Keywords
pathogenetic factors interact
femtoliters
How to Cite
Abstract
Characterizing the epidemiology of metabolic syndrome (MS) currently has a number of problems. On the one hand, quite a lot of data has been accumulated on the prevalence of both the syndrome and its individual components in various regions of the planet. On the other hand, comparison of the obtained data is almost impossible due to the lack of standardization in the studies conducted (2,4).
References
Бокарев, И. Н. Метаболический синдром // И. Н. Бокарев // Журнал клиническая медицина. – 2014. – Т. 9. - № 8 – С.71.
Гинзбург, М. М. Ожирение и метаболический синдром. Влияние на состояние здоровья, профилактика и лечение / М. М. Гинзбург, Г. С. Козупица, Н. Н. Крюков – М.: Эксмо, 2009. – 80 с.
Brotman, D.J. The Metabolic syndrome: A tug-of-war with no winner / D. J. Brotman, J. P. Girod // Clev. Cl. J. Med. – 2002. – Vol. 69. - № 12. – P. 990-994.
Dao, H. H. Body composition and metabolic syndrome in patients with primary gout in Vietnam / H. H. Dao, M. Harun Or-Rashid, J. Sakamoto // Rheumatology (Oxford). – 2010. – Vol. 49. – P. 2400-2407.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Sh. M. Mamasoliev, M.A. Artikova, J.A. Nazarova